4//SEC Filing
Lacey David L. 4
Accession 0001724521-25-000088
CIK 0001724521other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:28 PM ET
Size
17.4 KB
Accession
0001724521-25-000088
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+38,300→ 38,300 totalExercise: $10.02Exp: 2035-06-09→ Common Stock (38,300 underlying) - Award
Common Stock
2025-06-10+13,300→ 70,952 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001734422
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:28 PM ET
- Size
- 17.4 KB